Cargando…
Intensive Serial Biomarker Profiling for the Prediction of Neutropenic Fever in Patients with Hematologic Malignancies Undergoing Chemotherapy: A Pilot Study
Neutropenic fever (NF) is a life-threatening complication of myelosuppressive chemotherapy in patients with hematologic malignancies and triggers the administration of broad-spectrum antimicrobials. The ability to accurately predict NF would permit initiation of antimicrobials earlier in the course...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091290/ https://www.ncbi.nlm.nih.gov/pubmed/25013718 http://dx.doi.org/10.4081/hr.2014.5466 |
_version_ | 1782480751560753152 |
---|---|
author | Chan, Steven M. Chadwick, John Young, Daniel L. Holmes, Elizabeth Gotlib, Jason |
author_facet | Chan, Steven M. Chadwick, John Young, Daniel L. Holmes, Elizabeth Gotlib, Jason |
author_sort | Chan, Steven M. |
collection | PubMed |
description | Neutropenic fever (NF) is a life-threatening complication of myelosuppressive chemotherapy in patients with hematologic malignancies and triggers the administration of broad-spectrum antimicrobials. The ability to accurately predict NF would permit initiation of antimicrobials earlier in the course of infection with the goal of decreasing morbid complications and progression to septic shock and death. Changes in the blood level of inflammatory biomarkers may precede the occurrence of NF. To identify potential biomarkers for the prediction of NF, we performed serial measurements of nine biomarkers [C-reactive protein (CRP), protein C, interleukin (IL)-6, IL-8, IL-10, IL-1β, tumor necrosis factor-α, monocyte chemotactic protein-1, and intercellular adhesion molecule-1] using a multiplex ELISA array platform every 6-8 hours in patients undergoing myelosuppressive chemotherapy for hematologic malignancies. We found that the blood levels of IL-6 and CRP increased significantly 24 to 48 hours prior to the onset of fever. In addition, we showed that frequent biomarker monitoring is feasible using a bedside micro sample test device. The results of this pilot study suggest that serial monitoring of IL-6 and CRP levels using a bedside device may be useful in the prediction of NF. Prospective studies involving a larger cohort of patients to validate this observation are warranted. This trial is registered at ClinicalTrials.gov (NCT01144793). |
format | Online Article Text |
id | pubmed-4091290 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | PAGEPress Publications, Pavia, Italy |
record_format | MEDLINE/PubMed |
spelling | pubmed-40912902014-07-10 Intensive Serial Biomarker Profiling for the Prediction of Neutropenic Fever in Patients with Hematologic Malignancies Undergoing Chemotherapy: A Pilot Study Chan, Steven M. Chadwick, John Young, Daniel L. Holmes, Elizabeth Gotlib, Jason Hematol Rep Article Neutropenic fever (NF) is a life-threatening complication of myelosuppressive chemotherapy in patients with hematologic malignancies and triggers the administration of broad-spectrum antimicrobials. The ability to accurately predict NF would permit initiation of antimicrobials earlier in the course of infection with the goal of decreasing morbid complications and progression to septic shock and death. Changes in the blood level of inflammatory biomarkers may precede the occurrence of NF. To identify potential biomarkers for the prediction of NF, we performed serial measurements of nine biomarkers [C-reactive protein (CRP), protein C, interleukin (IL)-6, IL-8, IL-10, IL-1β, tumor necrosis factor-α, monocyte chemotactic protein-1, and intercellular adhesion molecule-1] using a multiplex ELISA array platform every 6-8 hours in patients undergoing myelosuppressive chemotherapy for hematologic malignancies. We found that the blood levels of IL-6 and CRP increased significantly 24 to 48 hours prior to the onset of fever. In addition, we showed that frequent biomarker monitoring is feasible using a bedside micro sample test device. The results of this pilot study suggest that serial monitoring of IL-6 and CRP levels using a bedside device may be useful in the prediction of NF. Prospective studies involving a larger cohort of patients to validate this observation are warranted. This trial is registered at ClinicalTrials.gov (NCT01144793). PAGEPress Publications, Pavia, Italy 2014-06-23 /pmc/articles/PMC4091290/ /pubmed/25013718 http://dx.doi.org/10.4081/hr.2014.5466 Text en ©Copyright S.M. Chan et al. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Chan, Steven M. Chadwick, John Young, Daniel L. Holmes, Elizabeth Gotlib, Jason Intensive Serial Biomarker Profiling for the Prediction of Neutropenic Fever in Patients with Hematologic Malignancies Undergoing Chemotherapy: A Pilot Study |
title | Intensive Serial Biomarker Profiling for the Prediction of Neutropenic Fever in Patients with Hematologic Malignancies Undergoing Chemotherapy: A Pilot Study |
title_full | Intensive Serial Biomarker Profiling for the Prediction of Neutropenic Fever in Patients with Hematologic Malignancies Undergoing Chemotherapy: A Pilot Study |
title_fullStr | Intensive Serial Biomarker Profiling for the Prediction of Neutropenic Fever in Patients with Hematologic Malignancies Undergoing Chemotherapy: A Pilot Study |
title_full_unstemmed | Intensive Serial Biomarker Profiling for the Prediction of Neutropenic Fever in Patients with Hematologic Malignancies Undergoing Chemotherapy: A Pilot Study |
title_short | Intensive Serial Biomarker Profiling for the Prediction of Neutropenic Fever in Patients with Hematologic Malignancies Undergoing Chemotherapy: A Pilot Study |
title_sort | intensive serial biomarker profiling for the prediction of neutropenic fever in patients with hematologic malignancies undergoing chemotherapy: a pilot study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091290/ https://www.ncbi.nlm.nih.gov/pubmed/25013718 http://dx.doi.org/10.4081/hr.2014.5466 |
work_keys_str_mv | AT chanstevenm intensiveserialbiomarkerprofilingforthepredictionofneutropenicfeverinpatientswithhematologicmalignanciesundergoingchemotherapyapilotstudy AT chadwickjohn intensiveserialbiomarkerprofilingforthepredictionofneutropenicfeverinpatientswithhematologicmalignanciesundergoingchemotherapyapilotstudy AT youngdaniell intensiveserialbiomarkerprofilingforthepredictionofneutropenicfeverinpatientswithhematologicmalignanciesundergoingchemotherapyapilotstudy AT holmeselizabeth intensiveserialbiomarkerprofilingforthepredictionofneutropenicfeverinpatientswithhematologicmalignanciesundergoingchemotherapyapilotstudy AT gotlibjason intensiveserialbiomarkerprofilingforthepredictionofneutropenicfeverinpatientswithhematologicmalignanciesundergoingchemotherapyapilotstudy |